Mandeep Garewal, MD
Diagnostic Neuroimaging · Ormond Beach, FLNPI 1700997707
Payments from drug & device makers
Across 638 payments — averaging $37.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$11K
- Novartis$2K
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$816
- Neurocrine Biosciences, Inc.$563
- Pfizer$454
- plus $7K from 54 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
Too few diagnostic neuroimaging providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic neuroimaging in Ormond Beach
- James ScottOrmond Beach$4.7M
- David McDonaldOrmond Beach$1.3M
- Dalia FulopOrmond Beach$210K
- Olimpio CunhaOrmond Beach$3K
- Michael EspositoTampa$16K
- Anisha GulatiStuart$415
- Jeffrey BongPort St Lucie$317
- Christopher SchaefferLeesburg$51
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.